Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

BACKGROUND: The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive description of country-specific health technology assessmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Orphanet J Rare Dis
Main Authors: Malinowski, Krzysztof Piotr, Kawalec, Paweł, Trąbka, Wojciech, Sowada, Christoph, Petrova, Guenka, Manova, Manoela, Savova, Alexandra, Draganić, Pero, Slabý, Juraj, Männik, Agnes, Márky, Kristóf, Rugaja, Zinta, Gulbinovic, Jolanta, Tesar, Tomas, Paveliu, Marian Sorin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545889/
https://ncbi.nlm.nih.gov/pubmed/33032634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01556-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados